litlas
Log inCreate account

Hartmut Land

Active 1981–2024

44
Papers
18,571
Citations
40
h-index
41
i10-index

Citations

Citations per year for Hartmut Land1974: 1 citations1981: 1 citations1982: 15 citations1983: 79 citations1984: 164 citations1985: 166 citations1986: 156 citations1987: 130 citations1988: 99 citations1989: 74 citations1990: 122 citations1991: 102 citations1992: 125 citations1993: 232 citations1994: 234 citations1995: 283 citations1996: 263 citations1997: 277 citations1998: 315 citations1999: 336 citations2000: 310 citations2001: 239 citations2002: 236 citations2003: 224 citations2004: 187 citations2005: 120 citations2006: 106 citations2007: 107 citations2008: 105 citations2009: 75 citations2010: 79 citations2011: 70 citations2012: 74 citations2013: 63 citations2014: 88 citations2015: 63 citations2016: 60 citations2017: 65 citations2018: 62 citations2019: 198 citations2020: 157 citations2021: 162 citations2022: 119 citations2023: 96 citations2024: 126 citations2025: 56 citations2026: 3 citations1975–1980: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,074 citing papers, 44.6% of this breakdownUnited Kingdom: 656 citing papers, 9.5% of this breakdownGermany: 418 citing papers, 6.1% of this breakdownCanada: 271 citing papers, 3.9% of this breakdownJapan: 266 citing papers, 3.8% of this breakdownChina: 242 citing papers, 3.5% of this breakdownFrance: 241 citing papers, 3.5% of this breakdownItaly: 204 citing papers, 3% of this breakdownSpain: 148 citing papers, 2.1% of this breakdownSwitzerland: 136 citing papers, 2% of this breakdownAustralia: 127 citing papers, 1.8% of this breakdownNetherlands: 124 citing papers, 1.8% of this breakdown
0%44.6%Other 14.4%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology49.9%
  • Medicine36.4%
  • Neuroscience5.7%
  • Immunology and Microbiology4.3%
  • Agricultural and Biological Sciences0.9%
  • Psychology0.9%
  • Other1.9%

Topics

  • Cancer-related Molecular Pathways6.8%
  • Cell death mechanisms and regulation3.3%
  • Ubiquitin and proteasome pathways2.7%
  • Virus-based gene therapy research2.7%
  • Epigenetics and DNA Methylation1.9%
  • Protein Kinase Regulation and GTPase Signaling1.6%
  • Other81%

Coauthors

All papers

Open in search
  1. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line

    Authors: Jay P. Morgenstern, Hartmut Land - Nucleic Acids Research 1990 cited by 2,143

  2. Induction of apoptosis in fibroblasts by c-myc protein

    Authors: Gérard I. Evan, Andrew H. Wyllie, Christopher S. Gilbert, Trevor D. Littlewood, Hartmut Land, Mary W. Brooks, Catherine Waters, Linda Z. Penn, David C. Hancock - Cell 1992 cited by 2,977

  3. Oncogenic activity of the c-Myc protein requires dimerization with Max

    Authors: Bruno Amati, Mary W. Brooks, Naomi Levy-Strumpf, Trevor D. Littlewood, Gérard I. Evan, Hartmut Land - Cell 1993 cited by 576

  4. Addiction to Coupling of the Warburg Effect with Glutamine Catabolism in Cancer Cells

    Authors: Bradley Smith, Xenia Schafer, Aslihan Ambeskovic, Cody M. Spencer, Hartmut Land, Joshua Munger - Cell Reports 2016 cited by 173

  5. Anticancer Activity of the Cholesterol Exporter ABCA1 Gene

    Authors: Bradley Smith, Hartmut Land - Cell Reports 2012 cited by 211

  6. KrasG12D and p53 Mutation Cause Primary Intrahepatic Cholangiocarcinoma

    Authors: Michael R. O’Dell, Jing Huang, Christa L. Whitney‐Miller, Vikram Deshpande, Paul G. Rothberg, Valerie Grose, Randall M. Rossi, Andrew X. Zhu, Hartmut Land, Nabeel Bardeesy, Aram F. Hezel - Cancer Research 2012 cited by 193

  7. Myc—Max—Mad: a transcription factor network controlling cell cycle progression, differentiation and death

    Authors: Bruno Amati, Hartmut Land - Current Opinion in Genetics & Development 1994 cited by 373

  8. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max

    Authors: Bruno Amati, Stephen Dalton, Mary W. Brooks, Trevor D. Littlewood, Gérard I. Evan, Hartmut Land - Nature 1992 cited by 476

  9. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

    Authors: Hartmut Land, Luis F. Parada, Robert A. Weinberg - Nature 1983 cited by 2,866

  10. Arid1a mutation suppresses TGF-β signaling and induces cholangiocarcinoma

    Authors: Bing Guo, Scott Friedland, W. Brock Alexander, Jacquelyn Myers, Wenjia Wang, Michael R. O’Dell, Michael Getman, Christa L. Whitney‐Miller, Diana Agostini‐Vulaj, Aaron R. Huber, Stephano S. Mello, Paula M. Vertino, Hartmut Land, Laurie A. Steiner, Aram F. Hezel - Cell Reports 2022 cited by 38

  11. On non-detects in qPCR data

    Authors: Matthew N. McCall, Helene R. McMurray, Hartmut Land, Anthony Almudevar - Bioinformatics, Bioinform. 2014 cited by 175

  12. Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth

    Authors: Xiaoyu Hu, Pranabananda Dutta, Amy Tsurumi, Jinghong Li, Jingtong Wang, Hartmut Land, Willis X. Li - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 82

  13. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation

    Authors: Luis F. Parada, Hartmut Land, Robert A. Weinberg, D. Wolf, Varda Rotter - Nature 1984 cited by 756

  14. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells.

    Authors: Oliver Bögler, Damian Wren, Susan C. Barnett, Hartmut Land, M Noble - National Academy of Sciences, Proceedings of the National Academy of Sciences 1990 cited by 572

  15. Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin–neurophysin II precursor

    Authors: Hartmut Land, Günther Schütz, Hartwig Schmale, Dietmar Richter - Nature 1982 cited by 571

  16. Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype

    Authors: Helene R. McMurray, Erik R. Sampson, George Compitello, Conan G. Kinsey, Laurel Newman, Bradley Smith, Shaw-Ree Chen, Lev B. Klebanov, Peter Salzman, Andrei Yakovlev, Hartmut Land - Nature 2008 cited by 171

  17. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ

    Authors: Timothy C. Thompson, Jennifer Southgate, Gay Kitchener, Hartmut Land - Cell 1989 cited by 357

  18. Plac8 Links Oncogenic Mutations to Regulation of Autophagy and Is Critical to Pancreatic Cancer Progression

    Authors: Conan G. Kinsey, Vijaya Balakrishnan, Michael R. O’Dell, Jing Huang, Laurel Newman, Christa L. Whitney‐Miller, Aram F. Hezel, Hartmut Land - Cell Reports 2014 cited by 84

  19. High-Intensity Raf Signal Causes Cell Cycle Arrest Mediated by p21 Cip1

    Authors: A. Sewing, Bryony Wiseman, Alison C. Lloyd, Hartmut Land - Molecular and Cellular Biology 1997 cited by 462

  20. Cyclins D1 and D2 mediate Myc‐induced proliferation via sequestration of p27Kip1 and p21Cip1

    Authors: Ignacio Pérez‐Roger, Soo‐Hyun Kim, B Griffiths, A. Sewing, Hartmut Land - The EMBO Journal 1999 cited by 331

  21. Negative autoregulation of c‐myc transcription.

    Authors: Linda Z. Penn, Mary W. Brooks, Ed Laufer, Hartmut Land - The EMBO Journal 1990 cited by 251

  22. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes

    Authors: Ignacio Pérez‐Roger, David LC Solomon, A. Sewing, Hartmut Land - Oncogene 1997 cited by 228

  23. Ras‐mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation.

    Authors: Anne J. Ridley, Hugh F. Paterson, Mark Noble, Hartmut Land - The EMBO Journal 1988 cited by 217

  24. Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility

    Authors: Mingxuan Xia, Hartmut Land - Nature Structural & Molecular Biology 2007 cited by 122